VJHemOnc is committed to improving our service to you

SOHO 2020 | Rise of antibody-based treatments in myeloma

VJHemOnc is committed to improving our service to you

Sagar Lonial

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA, explores the rise of antibody-based treatment in multiple myeloma, including the approval of daratumumab, elotuzumab, and belantamab mafodotin. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter